A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
Clinical Trial ID NCT01172964
PubWeight™ 27.41‹?›
🔗 Visit the ClinicalTrials.gov page for NCT01172964
Top papers
| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
Next 100